GLOBAL TUBERCULOSIS REPORT 2019

About:

• The world is not on track to reach the 2020 milestones of the End TB Strategy. The END TB strategy by the WHO aimed to reduce TB by 20 per cent from 2015-18. However, between 2015 and 2018, only 6.3 per cent TB cases showed a cumulative decline.
  
  
• In 2018, 7 million new cases of TB were notified — an increase from 6.4 million notified in 2017.
  
  
• Further, cases of the multi-drug resistant (MDR-TB) and rifampicin-resistant TB (RR-TB) have also increased. Rifampicin is the first-line of drug used to treat TB.
  
  

Indian Scenario:

• The report estimated that 10 million people had TB in 2018. India accounted for 27 per cent of the world total. China was a distant second with 9 per cent.
  
  
• India also had 27 per cent of a total 130,000 drug-resistant TB cases while China had 14 per cent and the Russian Federation 9 per cent
  
  
• The tuberculosis incidence rate in India has decreased by almost 50,000 patients over the past one year. In 2017, India had 27.4 lakh TB patients which came down to 26.9 lakh in 2018.
  
  
• Incidence per 1,00,000 population has decreased from 204 in 2017 to 199 in 2018.
  
  
• The number of patients being tested for rifampicin resistance has increased from 32% in 2017 to 46% in 2018.
  
  
• And the treatment success rate has increased to 81% for new and relapse cases (drug sensitive) in 2017, which was 69% in 2016.